Quantbot Technologies’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $230K | Buy |
4,448
+386
| +10% | +$19.7K | 0.01% | 1131 |
|
|
2025
Q4 | $202K | Buy |
4,062
+713
| +21% | +$34.7K | 0.01% | 1234 |
|
|
2025
Q3 | $160K | Sell |
3,349
-15,217
| -82% | -$613K | ﹤0.01% | 1360 |
|
|
2025
Q2 | $585K | Buy |
18,566
+15,416
| +489% | +$494K | 0.02% | 958 |
|
|
2025
Q1 | $103K | Buy |
+3,150
| New | +$112K | ﹤0.01% | 1235 |
|
|
2024
Q4 | – | Sell |
-1,026
| Closed | -$32K | – | 1812 |
|
|
2024
Q3 | $32K | Sell |
1,026
-21,601
| -95% | -$674K | ﹤0.01% | 1326 |
|
|
2024
Q2 | $605K | Buy |
+22,627
| New | +$656K | 0.03% | 695 |
|
|
2024
Q1 | – | Sell |
-6,701
| Closed | -$194K | – | 1934 |
|
|
2023
Q4 | $194K | Buy |
+6,701
| New | +$178K | 0.01% | 1026 |
|
|
2023
Q3 | – | Sell |
-3,331
| Closed | -$100K | – | 1944 |
|
|
2023
Q2 | $100K | Buy |
+3,331
| New | +$117K | 0.01% | 1178 |
|
|
2023
Q1 | – | Sell |
-531
| Closed | -$18.9K | – | 2043 |
|
|
2022
Q4 | $18.9K | Sell |
531
-1,158
| -69% | -$40.2K | ﹤0.01% | 1451 |
|
|
2022
Q3 | $57K | Buy |
+1,689
| New | +$55K | ﹤0.01% | 1222 |
|
|
2021
Q4 | – | Sell |
-6,183
| Closed | -$164K | – | 1902 |
|
|
2021
Q3 | $164K | Buy |
+6,183
| New | +$166K | 0.01% | 853 |
|
|
2021
Q2 | – | Sell |
-1,731
| Closed | -$45K | – | 1849 |
|
|
2021
Q1 | $45K | Buy |
+1,731
| New | +$48.4K | ﹤0.01% | 1032 |
|
|
2019
Q2 | – | Sell |
-5,562
| Closed | -$194K | – | 1420 |
|
|
2019
Q1 | $194K | Sell |
5,562
-138
| -2% | -$5.13K | 0.02% | 659 |
|
|
2018
Q4 | $189K | Buy |
5,700
+3,448
| +153% | +$148K | 0.02% | 654 |
|
|
2018
Q3 | $113K | Buy |
+2,252
| New | +$111K | 0.01% | 853 |
|
|
2018
Q2 | – | Sell |
-2,212
| Closed | -$101K | – | 1476 |
|
|
2018
Q1 | $101K | Sell |
2,212
-5,181
| -70% | -$216K | 0.01% | 846 |
|
|
2017
Q4 | $294K | Buy |
7,393
+1,185
| +19% | +$46.8K | 0.03% | 626 |
|
|
2017
Q3 | $248K | Buy |
+6,208
| New | +$269K | 0.02% | 660 |
|
|
2016
Q3 | – | Sell |
-877
| Closed | -$17K | – | 1315 |
|
|
2016
Q2 | $17K | Buy |
+877
| New | +$15.6K | ﹤0.01% | 934 |
|
|
2015
Q3 | – | Sell |
-10,889
| Closed | -$184K | – | 1413 |
|
|
2015
Q2 | $184K | Buy |
10,889
+10,289
| +1,715% | +$146K | 0.03% | 461 |
|
|
2015
Q1 | $7K | Buy |
+600
| New | +$5.67K | ﹤0.01% | 981 |
|
|
2014
Q2 | – | Sell |
-5,544
| Closed | -$49K | – | 1376 |
|
|
2014
Q1 | $49K | Buy |
+5,544
| New | +$51.1K | 0.01% | 787 |
|
Other funds holding SUPN
VPM
VCM
NAMI
AC
Quantbot Technologies's SUPN Position: Q1 2026 in Review
Quantbot Technologies increased its Supernus Pharmaceuticals (SUPN) stake by 9.5% in Q1 2026, buying an estimated $19.7K and bringing the position to 4,448 shares worth $230K. The position accounts for 0.01% of the portfolio, ranked #1131.
Quantbot Technologies first reported a position in SUPN in Q1 2014 and has held it in 23 quarters since. The position peaked at $605K in Q2 2024. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.
- Quantbot Technologies held 4,448 shares of Supernus Pharmaceuticals worth $230K as of Q1 2026.
- Quantbot Technologies bought 386 Supernus Pharmaceuticals shares in Q1 2026, an estimated $19.7K.
- Supernus Pharmaceuticals made up 0.01% of Quantbot Technologies's portfolio in Q1 2026, its #1131 holding.
- Quantbot Technologies first reported a position in Supernus Pharmaceuticals in Q1 2014 and has held it in 23 quarters since.
- Quantbot Technologies's Supernus Pharmaceuticals position peaked at $605K in Q2 2024.
- 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.
Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.